Proteomics International Laboratories Dirección
Dirección controles de criterios 2/4
El CEO de Proteomics International Laboratories' es Richard Lipscombe , nombrado en Jan 2001, tiene una permanencia de 23.25 años. compensación anual total es A$442.00K, compuesta por 79.2% salario y 20.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 12.54% de las acciones de la empresa, por valor de A$18.22M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 2.2 años, respectivamente.
Información clave
Richard Lipscombe
Chief Executive Officer (CEO)
AU$442.0k
Compensación total
| Porcentaje del salario del CEO | 79.2% |
| Permanencia del CEO | 23.3yrs |
| Participación del CEO | 12.5% |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 2.3yrs |
Actualizaciones recientes de la dirección
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable
Nov 16
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being
Nov 17Recent updates
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable
Nov 16Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)
Sep 29We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely
May 10Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being
Nov 17Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?
Aug 09We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth
Oct 20We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn
May 31Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$6m |
| Sep 30 2023 | n/a | n/a | -AU$6m |
| Jun 30 2023 | AU$442k | AU$350k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$6m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$330k | AU$265k | -AU$5m |
| Mar 31 2022 | n/a | n/a | -AU$5m |
| Dec 31 2021 | n/a | n/a | -AU$4m |
| Sep 30 2021 | n/a | n/a | -AU$4m |
| Jun 30 2021 | AU$298k | AU$250k | -AU$3m |
| Mar 31 2021 | n/a | n/a | -AU$3m |
| Dec 31 2020 | n/a | n/a | -AU$2m |
| Sep 30 2020 | n/a | n/a | -AU$2m |
| Jun 30 2020 | AU$299k | AU$250k | -AU$2m |
| Mar 31 2020 | n/a | n/a | -AU$2m |
| Dec 31 2019 | n/a | n/a | -AU$2m |
| Sep 30 2019 | n/a | n/a | -AU$2m |
| Jun 30 2019 | AU$207k | AU$185k | -AU$2m |
| Mar 31 2019 | n/a | n/a | -AU$2m |
| Dec 31 2018 | n/a | n/a | -AU$2m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$156k | AU$170k | -AU$1m |
| Mar 31 2018 | n/a | n/a | -AU$1m |
| Dec 31 2017 | n/a | n/a | -AU$1m |
| Sep 30 2017 | n/a | n/a | -AU$1m |
| Jun 30 2017 | AU$27k | AU$170k | -AU$916k |
Compensación vs. Mercado: La compensación total ($USD285.07K) de Richard está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD289.12K).
Compensación vs. Ingresos: La compensación de Richard ha aumentado mientras la empresa no es rentable.
CEO
Richard Lipscombe
23.3yrs
Permanencia
AU$442,000
Compensación
Dr. Richard John Lipscombe, Ph D (London), MA (Oxford), co-founded Proteomics International Laboratories Limited in 2001 and serves as its Managing Director and Director since June 09, 2014. Mr. Lipscombe...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 23.3yrs | AU$442.00k | 12.54% A$ 17.2m | |
| Chief Financial Officer | 2.8yrs | AU$305.30k | 0% A$ 0 | |
| Head of Business Development | no data | sin datos | sin datos | |
| Head of Research | 2.3yrs | sin datos | sin datos | |
| Head of Product Development | 1.8yrs | sin datos | sin datos | |
| Chief Commercialisation Officer | 2.9yrs | AU$393.08k | sin datos | |
| Head of Clinical Studies | no data | sin datos | sin datos | |
| Company Secretary | no data | sin datos | sin datos |
2.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de PIQ se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 9.9yrs | AU$442.00k | 12.54% A$ 17.2m | |
| Independent Non-Executive Chairman | 2.5yrs | AU$129.66k | 0.090% A$ 123.5k | |
| Member of Clinical Advisory Board | 2.1yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 7.6yrs | AU$45.00k | 0.75% A$ 1.0m | |
| Independent Non-Executive Director | 2.5yrs | AU$73.12k | sin datos | |
| Independent Non-Executive Director | 6.5yrs | AU$49.73k | 0.79% A$ 1.1m | |
| Member of Clinical Advisory Board | 2.1yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | 2.1yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | no data | sin datos | sin datos | |
| Member of Clinical Advisory Board | 2.1yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | 2.1yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | no data | sin datos | sin datos |
2.3yrs
Permanencia media
Junta con experiencia: La junta directiva de PIQ no se considera experimentada (2.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.